Product information
From Health Canada
No match found
No other product was found with the same active ingredient group.
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Marketed
Current status date:
2015-12-21
Original market date: See footnote 1
1995-12-31
Product name:
DIPENTUM
DIN:
02063808
Product Monograph/Veterinary Labelling:
Date:
2024-04-19
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
ATNAHS PHARMA UK LIMITED
Sovereign House, Miles Gray Road
Basildon
Essex
Great Britain
SS14 3FR
Class:
Human
Dosage form(s):
Capsule
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
56:36.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
A07EC03 OLSALAZINE
Active ingredient group (AIG) number:See footnote5
0122225002
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| OLSALAZINE SODIUM | 250 MG |